Hyoscyamine ER
NDC 51525-0115, hyoscyamine sulfate, tablet, extended release, from Mylan Pharmaceuticals Inc..
- Product NDC
- 51525-0115
- Status
- Listed
- Labeler
- Mylan Pharmaceuticals Inc.
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- UNAPPROVED DRUG OTHER
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51525-0115 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- HYOSCYAMINE SULFATE.375 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51525-0115-1 | 51525011501 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (51525-0115-1) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/5bbce8c0-a9c9-45b9-8457-1542bd3d9449
Use it
Look up 51525-0115 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51525-0115 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51525-0115. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.